WuXi Biologics (Cayman) Inc., an investment holding ... that seamlessly transits to CMC and downstream process development through its contract research, development, and manufacturing ...

Drug research and development firms in China including WuXi AppTec and WuXi Biologics are changing project plans, stockpiling ...

Over the past few quarters, we have prioritized disease indications and built a foundation of key CMC and clinical operational activities to set a new benchmark for innovation, scale, and speed.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Wuxi Biologics (Cayman) Inc. + Watchlist Alert WXIBF US Closed Last Updated: Jun 17, 2025 11:05 a.m. EDT Delayed quote $ 3.2500 0.0400 1.25% Previous Close $3.2100 Toggle Chart Options Advanced ...

MSD has expanded its presence in Ireland with an agreement to buy a vaccine manufacturing facility from Chinese biotech WuXi Biologics for around €500 million (around $520 million). The plant in ...

US intelligence services advised the authors of the BIOSECURE Act that that WuXi AppTec shared confidential data on US customers with the Chinese government, according to a Reuters report.

The introduction of biologics has changed treatment for many people with ulcerative colitis. Here’s what you need to know about the risks and benefits. Over the past 15 years, treatment options ...

1 Day 2269 0.00% DJIA 0.08% S&P 500 -0.22% Health Care/Life Sciences 0.47% ...

The Biocon Biologics Global PLC-Bond has a maturity date of 10/9/2029 and offers a coupon of 6.6700%. The payment of the coupon will take place 2,0 times per biannual on the 09.04.. The Biocon ...